The global sleep apnea devices market is expanding as awareness of sleep-related breathing disorders increases and healthcare providers focus on early diagnosis and effective treatment. Sleep apnea is a condition characterized by repeated interruptions in breathing during sleep, which can affect oxygen supply and overall health. The growing availability of diagnostic equipment, therapeutic devices, and home-based treatment solutions is creating opportunities for manufacturers and healthcare providers. These devices support the identification and management of sleep apnea across hospitals, sleep laboratories, clinics, and homecare settings.

According to Fortune Business Insights, the global sleep apnea devices market size was USD 10.30 billion in 2025 and is projected to grow from USD 11 billion in 2026 to USD 22.87 billion in 2034, exhibiting a CAGR of 9.59% during the forecast period. North America dominated the sleep apnea devices market with a market share of 49.55% in 2025.

The sleep apnea devices market size reflects increasing demand for technologies that support sleep disorder diagnosis and treatment. Improvements in portable diagnostic systems, positive airway pressure devices, and oral appliances are also contributing to the development of the industry.

Top Companies In The Market

The competitive landscape includes medical device manufacturers specializing in respiratory care, sleep diagnostics, and therapeutic equipment. Leading companies are focusing on product innovation, technological improvements, and expanding access to sleep apnea management solutions.

• Koninklijke Philips N.V. (Netherlands)

• Openairway (Australia)

• Cadwell Industries, Inc. (U.S.)

• ResMed (U.S.)

• Fisher & Paykel Healthcare Limited (New Zealand)

• Invacare Corporation (U.S.)

• SomnoMed (Australia)

• Compumedics Limited (Australia)

• Braebon Medical Corporation (Canada)

Market Drivers & Restraints:

Increasing Prevalence of Obstructive Sleep Apnea: The rising prevalence of obstructive sleep apnea (OSA) is a major factor supporting demand for sleep apnea devices. Lifestyle-related factors, obesity, elevated stress, and poor sleep patterns are contributing to the growing burden of the condition. The increasing incidence of associated health conditions, including hypertension and cardiovascular disorders, is also encouraging greater attention to sleep-related breathing problems. Growing awareness and diagnosis rates are expected to support the adoption of diagnostic and therapeutic devices.

Growing Preference for Advanced and Convenient Devices: Patients are increasingly showing interest in devices that offer comfort and convenience during sleep apnea management. Oral appliances, including mandibular advancement devices, are gaining attention as alternatives for certain patients. Portable diagnostic technologies, such as actigraphy systems, are also attracting interest because of their non-invasive nature and suitability for monitoring sleep-related patterns. These developments are encouraging manufacturers to introduce improved products.

Expansion of Home-Based Sleep Apnea Management: The growing availability of portable equipment is supporting the use of sleep apnea devices outside traditional clinical environments. Homecare solutions can provide patients with greater convenience and support ongoing treatment management. The increasing focus on home sleep apnea testing is also creating opportunities for manufacturers developing compact diagnostic equipment and user-friendly therapeutic systems.

High Device Costs and Reimbursement Limitations: The cost of diagnostic and therapeutic equipment can restrict adoption, particularly among patients without adequate medical insurance. Advanced devices may require significant investment, while limited reimbursement policies and high out-of-pocket expenses can create additional barriers in developing countries. These financial challenges may affect access to diagnosis and treatment and limit market penetration.

Market Competitive Landscape:

The global sleep apnea devices market includes established medical technology companies and specialized manufacturers. ResMed and Koninklijke Philips N.V. are among the major participants, alongside other companies developing diagnostic and therapeutic products. Market participants compete through product launches, technological improvements, distribution expansion, and the development of convenient solutions for patients and healthcare professionals.

Product innovation is an important part of competitive strategies. In February 2024, the U.S. FDA approved AIO BREATHE, a mandibular repositioning device developed to address demand for oral appliances used in obstructive sleep apnea management. Such developments reflect growing interest in alternatives that emphasize patient comfort and treatment convenience.

Companies are also focusing on portable diagnostic solutions and advanced therapeutic equipment. These initiatives are helping expand product choices across clinical and homecare environments. Manufacturers that improve device accessibility, usability, and performance can strengthen their position in an increasingly competitive industry.

Market Segments:

The global sleep apnea devices market is segmented by 

By Device Type (Therapeutic Devices [Positive Airway Pressure Devices {Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BiPAP) Devices, and Others}, Masks and Accessories, and Others] and Diagnostic Devices [Polysomnography Devices, Pulse Oximeter, Actigraphy Devices, and Others])

By End User (Sleep Laboratories & Clinics and Homecare & Other Settings)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/sleep-apnea-devices-market-100708 

Market Regional Insights:

North America: North America dominated the global market in 2025, generating USD 5.11 billion and accounting for 49.55% of global revenue. The regional market is projected to reach USD 5.48 billion in 2026. The high prevalence of obstructive sleep apnea, favorable reimbursement policies, and increasing adoption of diagnostic and therapeutic equipment support regional demand. The U.S. market is projected to reach USD 5.10 billion in 2026.

Europe: Europe generated USD 2.71 billion in 2025, representing 26.27% of the global market, and is expected to reach USD 2.89 billion in 2026. Growing awareness of sleep apnea and increasing demand for diagnostic tests are supporting regional development. The U.K. market is projected to reach USD 0.47 billion in 2026, while Germany is expected to reach USD 0.73 billion.

Asia Pacific: Asia Pacific accounted for USD 1.61 billion in 2025, representing 15.63% of global revenue, and is projected to reach USD 1.71 billion in 2026. Increasing demand in Japan and Australia, rising awareness in emerging economies, and growing interest in home sleep apnea testing are supporting regional growth. Japan's market is projected to reach USD 0.47 billion in 2026, while China and India are expected to reach USD 0.62 billion and USD 0.19 billion, respectively.

Future Market Scope:

The future of the sleep apnea devices market will be influenced by technological innovation, increasing diagnosis rates, and the growing adoption of home-based treatment solutions. Manufacturers are expected to focus on developing portable diagnostic systems, improved positive airway pressure devices, comfortable masks, and oral appliances. These developments may help address patient preferences and expand access to sleep apnea management.

Further opportunities may emerge from the integration of advanced monitoring technologies and the development of convenient diagnostic equipment. Greater awareness of sleep disorders and the expansion of sleep laboratories and clinics may also support demand. However, affordability, reimbursement limitations, and patient adherence will remain important considerations for the industry.

Explore Japan’s Market Opportunities - Latest -Sleep Apnea Devices Market- Insights